A biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. Using proprietary viral vectors and semi-automated cell manufacturing processes, they produce precisely targeted, controlled and highly activated therapies.
Visit website
Location:
Forest House, 58 Wood Lane, White City, London, W12 7RZ
Categories:
The Synthetic Proteome
Founded in:
2014
Employee number:
100+
Annual revenue:
$1.7M